These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12381907)
1. Irregularity of parenchymal echo patterns of liver analyzed with a neural network and risk of hepatocellular carcinoma in liver cirrhosis. Fukuda H; Ebara M; Kobayashi A; Sugiura N; Yoshikawa M; Saisho H; Kato K; Kondo F; Yahagi T Oncology; 2002; 63(3):270-9. PubMed ID: 12381907 [TBL] [Abstract][Full Text] [Related]
2. Parenchymal echo patterns of cirrhotic liver analysed with a neural network for risk of hepatocellular carcinoma. Fukuda H; Ebara M; Kobayashi A; Sugiura N; Yoshikawa M; Saisho H; Kondo F; Yahagi T J Gastroenterol Hepatol; 1999 Sep; 14(9):915-21. PubMed ID: 10535475 [TBL] [Abstract][Full Text] [Related]
3. Natural history of chronic hepatitis B REVEALed. Chen CJ; Yang HI J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729 [TBL] [Abstract][Full Text] [Related]
4. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Fasani P; Sangiovanni A; De Fazio C; Borzio M; Bruno S; Ronchi G; Del Ninno E; Colombo M Hepatology; 1999 Jun; 29(6):1704-7. PubMed ID: 10347111 [TBL] [Abstract][Full Text] [Related]
5. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area. Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806 [TBL] [Abstract][Full Text] [Related]
6. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis. Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149 [TBL] [Abstract][Full Text] [Related]
7. Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness? Feier D; Lupsor Platon M; Stefanescu H; Badea R J Gastrointestin Liver Dis; 2013 Sep; 22(3):283-9. PubMed ID: 24078985 [TBL] [Abstract][Full Text] [Related]
8. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
9. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis. Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863 [TBL] [Abstract][Full Text] [Related]
10. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142 [TBL] [Abstract][Full Text] [Related]
11. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients. Abdelgawad IA J Clin Pathol; 2015 Feb; 68(2):154-60. PubMed ID: 25430496 [TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor. Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940 [TBL] [Abstract][Full Text] [Related]
14. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Shibata M; Morizane T; Uchida T; Yamagami T; Onozuka Y; Nakano M; Mitamura K; Ueno Y Lancet; 1998 Jun; 351(9118):1773-7. PubMed ID: 9635950 [TBL] [Abstract][Full Text] [Related]
15. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation. Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618 [TBL] [Abstract][Full Text] [Related]
16. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938 [TBL] [Abstract][Full Text] [Related]
17. Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study. Harada T; Shigeta K; Noda K; Fukumoto Y; Nishimura H; Mizuta M; Takemoto T Hepatogastroenterology; 1980 Jun; 27(3):169-75. PubMed ID: 6161869 [TBL] [Abstract][Full Text] [Related]
18. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
19. Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns. Soresi M; Terranova A; Licata A; Serruto A; Montalto G; Brancatelli G; Giannitrapani L Biomed Res Int; 2017; 2017():4932759. PubMed ID: 28638828 [TBL] [Abstract][Full Text] [Related]
20. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]